Tumor associated antigen specific T cells therapy (Catherine Bollard Children'S Research Institute)

N/A

Report date: 2022/03/11 14:32:24

Base Information

Drug NameTumor associated antigen specific T cells therapy (Catherine Bollard Children'S Research Institute)
Drug Alias NameTAA-T cells肿瘤相关抗原特异性T细胞-Children's Research InstituteTumor associated antigen specific T cells
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy
Mechanisms of ActionT lymphocyte replacements
TargetsNot applicable
Therapy Area/IndicationsLymphoma, Large B-Cell, DiffuseHodgkin DiseaseLymphoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesCatherine Bollard Children'S Research Institute
China Registration ClassN/A

Develop Information

Active CompaniesCatherine Bollard Children'S Research Institute
Inactive CompaniesN/A
Active IndicationsLymphoma, Large B-Cell, DiffuseHodgkin DiseaseLymphoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A